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Abstract
Background: Pleurotus giganteus (Berk. Karunarathna and K.D. Hyde), has been used as a culinary mushroom and
is known to have medicinal properties but its potential as an anti-inflammatory agent to mitigate inflammation
triggered diseases is untapped. In this study, the molecular mechanism underlying the protective effect of ethanol
extract of P. giganteus (EPG) against lipopolysaccharide (LPS) and combination of LPS and hydrogen peroxide
(H2O2)-induced inflammation on RAW 264.7 macrophages was investigated.
Method: The effect of EPG on nitric oxide (NO) production as an indicator of inflammation in RAW 264.7 macrophages
was estimated based on Griess reaction that measures nitrite level. The expressions of inducible nitric oxide synthase
(iNOS), cyclooxygenase-2 (COX-2), NF-kB activating protein (NKAP), signal transducer and activator of transcription 3
protein (STAT 3) and glutathione peroxidase (GPx) genes were assessed using real time reverse transcription
polymerase chain reaction (RT-PCR) approach.
Results: EPG (10 μg/ml) showed the highest reduction in the LPS-induced NO production in RAW 264.7 macrophages
and significantly suppressed (p < 0.05) the expression iNOS, STAT 3 and COX-2. There was a significant increase
(p < 0.05) in combination of LPS and H2O2- induced iNOS production when compared to the LPS-induced iNOS
production in RAW 264.7 macrophages and this concurred with the NO production which was attenuated by
EPG at 10 μg/ml. A significant (p < 0.05) down regulation was observed in the combination of LPS and H2O2-
induced iNOS and GPx expression by EPG.
Conclusions: Our data suggest that the anti-inflammatory activity of EPG is mediated via the suppression of the
STAT 3 and COX-2 pathways and can serve as potential endogenous antioxidant stimulant.
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Background
Inflammation is the body’s network system that protects
humans against environmental agents that are foreign to
the body [1]. These harmful agents can be introduced
through cuts, invasion of microorganisms, food, chemi-
cals, or drugs. During inflammation, macrophages play a
crucial role in counteracting the invasion of pathogens
by releasing inflammatory mediators such as prostaglandin
and pro-inflammatory cytokines (TNF-alpha, IL-6, IL-1α
and IL-1β). These macrophages act upon the stimuli by a
process called phagocytosis. During this process, phago-
cytes generate toxic products, which include reactive
oxygen species such as nitric oxide (NO), hydrogen
peroxide (H2O2) and superoxide anion (O2
- ) that con-
tribute to oxidative stress at the cellular level. One of
the potent stimuli for macrophages is the bacterial
endotoxin (lipopolysaccharide), which activates the
macrophages through the Toll-like receptors 4 (TLR 4)
[2]. The process of recovering the cellular functions
and structure back to its normal condition is called the
acute phase of inflammation which is crucial to our
body. Although these inflammatory mediators are essen-
tial in the defence mechanism, their overproduction
causes chronic inflammation and the continuous destruc-
tion can be detrimental to tissues. Chronic inflammation
has been linked to the pathogenesis of various diseases
such as diabetes [3], Alzheimer’s [4], cardiovascular dis-
ease [5], and cancer [6] and these diseases have been
shown to be the leading causes of death.
To date, non-steroidal anti-inflammatory drugs
(NSAID’s) have been used as the treatment of choice for
inflammatory conditions. However, the consumption of
NSAID’s, has caused approximately 100,000 hospitalisa-
tions and 16,500 deaths due to gastrointestinal toxicity
each year in the United States of America [7]. Besides
gastrointestinal toxicity, Lacroix [8] reported that
NSAID’s can also cause liver damage. These findings
have motivated the search for anti-inflammatory treat-
ments with fewer side effects.
Herbal products have established their importance as
complementary therapies over the years but mushrooms
have been gaining popularity for their therapeutic proper-
ties more recently [9]. Mushrooms have been well recog-
nised as nutritional and functional foods and a source of
potent bioactive compounds. In Malaysia, the genus
Pleurotus, commonly referred to as ‘oyster mushrooms’,
are cultivated. This ‘edible fungal food’ was discovered to
have definite nutritive and medicinal values and has been
popular in countries such as India, China and Japan.
Pleurotus giganteus (Berk. Karunarathna and K.D. Hyde),
formerly known as Panus/Lentinus giganteus, has been
used as a culinary mushroom and is increasing in popu-
larity for its medicinal properties and commercial pros-
pects. Recently, it was reported that P. giganteus
contained bioactive compounds that mimic neurite
growth factor (NGF) which were accountable for neurite
stimulation [10], possessed liver protection properties [11]
and were a healthy dietary supplements for brain and cog-
nitive health [12]. Hence, the aim of this study was to
examine the anti-inflammatory effect of ethanol extract of
P. giganteus (EPG) on LPS and combination of LPS and
H2O2-induced RAW 264.7 macrophages. The effect of
EPG on NO production and inducible nitric oxide syn-
thase (iNOS), cyclooxygenase-2 (COX-2), NF-kB acti-
vating protein (NKAP), signal transducer and activator
of transcription 3 protein (STAT 3) and glutathione
peroxidase (GPx) expressions was investigated to unveil
the mechanism of EPG as an anti-inflammatory action.
Methods
Mushroom species
The fresh basidiocarps of P. giganteus (commercial strain
KLU-M 1227) were obtained from Nas Agro Farm,
Sepang, Selangor, Malaysia and Dong Foong Manufac-
turing Sdn. Bhd., Kajang, Selangor, Malaysia. The mush-
room identity (molecular fingerprinting) was authenticated
by Dr. Tan Yee Shin from Mushroom Research Centre,
University of Malaya. Voucher specimens were deposited
in the Herbarium of University of Malaya (KLU-M 1227).
Chemicals and reagents
Ethanol (99.8%) was purchased from System (Selangor,
Malaysia), and dimethyl sulfoxide (DMSO) was pur-
chased from Fisher Scientific Inc. (New Hampshire,
USA). Dulbecco’s Modified Eagle’s Medium (DMEM),
foetal bovine serum (FBS), Escherichia coli (O55:B5)
lipopolysaccharide (LPS), N ω -nitro-l-arginine-methyl
ester (L-NAME), sulphanilamide, N-(1-naphty) ethylene-
diamine and phosphoric acid (H3PO4) were obtained
Xfrom Sigma-Aldrich (St. Louis, MO, USA). 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide
(MTT) was purchased from Calbiochem, Merck Milli-
pore (Darmstadt, Germany). Penicillin-streptomycin and
fungizone were obtained from Biowest (MO, USA) and
phosphate buffer saline (PBS) was purchased from
Oxoid Ltd, Thermo Scientific (Hampshire, UK).
Sample preparation
The basidiocarps of P. giganteus were sliced and freeze-
dried for 48 h at -50 ± 2 °C. The freeze-dried basidio-
carps were then powdered in a commercial Waring
blender. The mushroom powder was kept in an airtight
bottle under -20 °C prior to extraction.
Preparation of ethanol extracts of P. giganteus (EPG)
The freeze-dried basidiocarp powder was soaked in a
mixture of ethanol and water at a ratio of 8:2 (1 L) for
three days at room temperature (25 °C). The solvent-
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containing extract was then decanted and filtered. The
extraction process was repeated three times. The filtrates
were then pooled, and the solvent was evaporated under
reduced pressure using a rotary evaporator to yield a
yellowish viscous extract [10].
Cell culture
The murine macrophage cell line (RAW 264.7), cata-
logue number TIB-71, and was obtained from American
Type Culture Collection, USA (ATCC). The cells were
maintained in Dulbecco’s modified Eagle’s medium
(DMEM, Sigma-Aldrich, St. Louis, MO, USA) supple-
mented with 10% heat-inactivated foetal bovine serum
(FBS, Sigma-Aldrich, St. Louis, MO, USA), 100 units/mL
of penicillin, 100 μg/mL of streptomycin, amphotericin
B (Biowest, Nuaillé - France) and L–glutamine (Sigma-
Aldrich, St. Louis, MO, USA) in a humidified atmos-
phere at 37 °C in 5% CO2. The medium was changed
every 3-4 days as needed. The cells were cultured to
reach at least 70% confluence prior to the assay [13].
Cell viability
Cell viability was determined using the 3 [4, 5-
dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide
(MTT) assay. In the assay, yellow tetrazolium salt was
reduced to insoluble purple formazan crystals by the
mitochondrial dehydrogenases of viable cells. The RAW
264.7 macrophage cells (5 × 104 cells per well) were
seeded in a 96-well flat-bottomed culture plate and incu-
bated at 37 °C overnight in a humidified environment of
5% CO2 and 95% air to allow cell adherence. Cells were
then treated with 0.01–100 μg/mL of ethanolic extract
of P. giganteus (EPG) for another 24 h. Subsequently,
5 mg/mL of MTT solution was added into each well and
further incubated for 4 h to allow formazan crystal for-
mation. The supernatant was then carefully removed,
and 100 μl of dimethyl sulfoxide (DMSO, D5879, Sigma-
Aldrich, St. Louis, MO, USA) was added into each well
to dissolve the MTT formazan crystal. The absorbance
was measured at 540 nm with a spectrophotometer
(BioTek Instruments). The complete growth medium
served as the blank, and cells incubated in medium only
without mushroom extracts were used as the positive
control [14].
NO production
Nitrite that accumulated in the medium was measured
as an indicator of NO production based on the Griess
reaction. The RAW 264.7 cells were plated in a 96-well
plate at a density of 4 × 105 cells/well in 100 μL of cul-
ture medium for 24 h. Cells were then co-incubated with
EPG (0.01–100 μg/mL) and 1 μg/mL of LPS for 24 h.
After 24 h, the spent medium was collected for nitrite
measurement. One-hundred microliters of the spent
medium was transferred into a new 96-well plate and an
equal amount of Griess reagent (0.1% N-1-[naphthyl]
ethylenediamine-diHCl, 1% sulphanilamide and 5%
H3PO4) was added to each well. The absorbance was
measured at 550 nm using a microplate reader (BioTek
Instruments) after a 15 min incubation period. The
amount of NO was calculated using a sodium nitrite
standard curve [14]. A strong iNOS inhibitor, NG-Nitro-
L-Arginine Methyl Ester (L-NAME), was used as a posi-
tive control in this experiment. The units were expressed
as nitrite in micromolar (μM).
Real time: RT-PCR
The total RNA was isolated from the macrophage cells
treated with EPG (10 μg/ml) using Ambion RNAqueous-
Micro Kit (Applied Biosystems, USA). The purity of
recovered total RNA was estimated by calculating the
ratio of absorbance reading between 260 nm and
280 nm. The integrity of RNA was estimated using
2100 Bioanalyzer (Agilent Technologies, USA). Puri-
fied RNA with a A260/A280 ratio between 1.8 and 2.0
and RIN values between 8 and 10 were used to
synthesize complementary DNA (cDNA) by the poly-
merase chain reaction (PCR) approach. A High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems,
USA) which contained all reagents needed for reverse
transcription (RT) of total RNA to single-stranded cDNA
was used in this study. The mixture was then loaded into
a thermal cycler (Eppendorf, USA), and PCR was carried
out according to optimized thermal cycling conditions
provided by the manufacturer. Table 1 shows the list of
genes investigated in this study and the corresponding
accession numbers. Endogenous control used in this
study was eukaryotic beta actin with FAM/MGB probe.
Dexamethasone and acetylsalicylic acid (aspirin) (a
Table 1 The general abbreviation of genes selected for this study and corresponding assay ID and accession number were obtained
from the Applied Biosystems website and NCBI database
No. Gene name and abbreviation Assay ID Accession number
1 Nuclear factor-κB (NF-κB) Mm 0482418_m1 NM_025937.4
2 Inducible nitric oxide synthase (iNOS) Mm 0440502_m1 NM_010927.3
3 signal transducer and activator of transcription 3 protein (STAT 3) Mm 1219775_m1 NM_011486.4
4 Glutathione peroxidase 3 (GPx 3) Mm00492427_m1 NM_008161.2
Assay ID refers to the Applied Biosystems Gene Expression Assays inventoried kits with proprietary primer and TaqMan® probe mix. Assay ID with ‘Mm’ is referred
to as ‘Mus musculus’. All Gene Expression Assay kits indicated are FAM/MGB probed
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commercially available anti-inflammatory drug) were used
as positive controls. The quantification approach used was
the comparative CT method, also known as 2-ΔΔCt
method [15].
Statistical analysis
The means of data were subjected to a one-way analysis
of variance (ANOVA) and the significance of difference
between means was determined by the Duncan’s mul-
tiple range tests. Values with p < 0.05 were regarded as
statistically significant. The software used to determine
the significance level was SPSS Statistics 17.0.
Results and discussion
Effects of EPG on cell viability
Mushrooms are among the most prominent functional
foods for humans. They are now known as the new
generation of “bio therapeutics” [16] with antioxidant,
anti-diabetic, anti-tumour, anti-hypertensive and anti-
inflammatory properties. The Natural Health Products
(NHPs) organization has shown interest, particularly in
the prevention and treatment of several inflammation-
caused chronic diseases, in using natural products.
Pleurotus giganteus is a newly cultivated mushroom
that is now being explored for its medicinal properties.
Inflammation can be defined as the orchestrated response
of inflammatory mediators such as pro-inflammatory
cytokines (TNF-α, IL-6, IL-1), prostaglandin, and the free
radical NO, against tissue injury or infection. Prior to the
determination of the potential anti-inflammatory activity
of EPG, the cytotoxic effect of EPG was assessed. Figure 1
shows the percentage of viable RAW 264.7 macrophages
incubated with various concentrations of EPG compared
to the untreated cells (negative control). A dose-
dependent increase of cell viability was observed at the
concentration range of 0.01–10 μg/ml of EPG tested. The
maximum dose (100 μg/ml) tested, showed a significant
(p < 0.05) decrease in cell viability. The cell viability for
this particular concentration was only 39.9% as compared
to the control. This could be due to the oversaturation of
compounds in that particular concentration which led the
cells to have a reduced viability. Hence, the concentration
of EPG used was limited to a maximum of 10 μg/ml.
Among all the concentration tested, 0.1, 1 and 10 μg/ml
showed a significant (p < 0.05) increase in cell viability
compared to the control. The EPG at 10 μg/ml showed
the highest viability (162.98%). The lower concentrations
did not affect the cell viability instead showed an increase
viability of the RAW 264.7 macrophages. However, at
higher concentration (100 μg/ml) the viability was signifi-
cantly reduced. Similar increase in viability was also
observed when EPG was tested with neurite cells (PC 12)
[10]. These non-cytotoxic extracts were then further
tested on LPS induced NO production in RAW 264.7
macrophage.
Effects of EPG on NO production
Although NO is responsible for the host defence mech-
anism [17], a high level of NO concentration can cause
toxicity and damage to host cells. Excessive NO produc-
tion is associated with pathogenesis of inflammatory dis-
eases including atherosclerosis [18], vascular disease [19]
and septic shock [20]. Bioactive compounds found in
plants have been shown for years to inhibit inflamma-
tory mediators. Lately, numerous mushrooms have
already been proven to have anti-inflammatory activity
by testing their inhibitory efficacy against the nitric
oxide production [21]. Ethanol extract of Russula vires-
cens, showed a reduction of the NO production in LPS-
activated RAW 264.7 macrophages [22]. Besides, metha-
nol extracts of edible mushrooms were also reported to
inhibit the production of NO [21]. Nitric oxide is
Fig. 1 Effects of ethanol extracts of P. giganteus (EPG) studied at different concentration on RAW 264.7 macrophage’s cell viability. Control = negative
control (untreated cells) taken as 100% viability. Each bar represents the mean cell viability defined as ratio of absorbance of treated to untreated cells
(%) ± SD of three independent experiments carried out in triplicates. The different alphabets denote significant difference (p < 0.05) from the
corresponding value of the negative control
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synthesized by iNOS and cyclooxygenase-2 (COX-2).
Overexpression of both iNOS and COX-2 is com-
monly associated with inflammation. Therefore, the
production of NO and the expression of iNOS and
COX-2 can be an important target in the treatment
or control of inflammation. Figure 2 illustrates the ef-
fect of EPG on NO production. The NO production
measured as nitrite was increased significantly (p <
0.05) to 21.75 μM when RAW 264.7 cells were in-
duced with 1 μg/ml of LPS, compared to 5.92 μM of
the negative control without LPS. The various con-
centrations of EPG (0.01, 0.1, 1 and 10 μg/ml)
showed significant (p < 0.05) reduction in LPS-induced
NO production in RAW 264.7 cells (44.1%, 62.1%,
57.5% and 74.7% respectively). L-NAME (a strong
iNOS inhibitor) caused a 63.5% reduction in the LPS-
induced NO production in RAW 264.7 macrophages
at a concentration of 100 μM while EPG at 10 μg/ml
also showed significant inhibitory potency. Interest-
ingly, ethanol extract of a very well-known mushroom
Ganoderma lucidum exerted similar inhibitory effect
on BV 2 microglial cells (a neuronal macrophage) but
at a higher concentration (1 mg/mL) [23]. Hence,
EPG (10 μg/ml) was used in the subsequent experi-
ments to further confirm the presence of anti-
inflammatory effects and unveil the possible mode of
action on the RAW 264.7 macrophage cells using gene
expression studies.
Effect of EPG on the inflammatory genes
To elucidate whether the inhibitory effect observed on
NO production (Fig. 2) by the extract was due to the
down-regulation of the iNOS and COX-2 expression,
gene expression study was conducted. Figure 3(a) shows
the iNOS expression in LPS stimulated RAW 264.7 cells
treated with 10 μg/ml of EPG. The expression of iNOS
Fig. 2 Effects of ethanol extracts of P. giganteus (EPG) studied at different concentrations on lipopolysaccharide (LPS) – induced nitric oxide (NO)
production by RAW 264.7 macrophage cells. Control = negative control (untreated cells); L-NAME = L-NG-nitro arginine Methyl Ester (100 μM).
Each bar represents the mean of NO production, defined as ratio of absorbance of treated to untreated cells (%) ± SD of three independent
experiments carried out in triplicates. The different alphabets denote significant difference (p < 0.05) from the corresponding value for control
Fig. 3 Effect of ethanol extract of P. giganteus (EPG) on the (a) iNOS and (b) COX-2 expression in lipopolysaccharide (LPS) stimulated RAW 264.7
macrophage cells. Results are expressed as fold of increase compared to LPS treatment as control. Fold increase values are calculated relative to
the ACTB gene. Control = cell treated with LPS only; Dexa = dexamethasone; Asp = Aspirin; EPG = ethanol extract of P. giganteus at 10 μg/mL. Data
expressed as mean ± S.D (n = 3). The different alphabets denote significant difference (p < 0.05) from the corresponding value for control
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was significantly (p < 0.05) reduced by 2.65 fold in EPG
treated cells when compared to the control. Dexametha-
sone and aspirin (commercially available anti-inflammatory
drug) also showed a significant (p < 0.05) down regulation
of the iNOS expression. Thus, it is feasible to suggest that
the inhibitory effect of EPG on LPS- induced NO produc-
tion was mediated by the inhibition of the iNOS expres-
sion. The level of expression of COX-2 in RAW 264.7
macrophages was also significantly (p < 0.05) inhibited by
EPG (Fig. 3(b)), mimicking the inhibitory pathway used by
aspirin and dexamethasone. It is well studied that NSAIDs
use COX-2 pathway in inhibiting inflammation [24].
It has been well documented that the expression of
iNOS is regulated by the transcription factors NF-κB
and STAT-3 and the exact pathway or mechanism
remains unclear. The suppression of JAK2-STATs activa-
tion was reported to result in the inhibition of the
LPS–induced production of NO and also the expression
of iNOS [25], which is consistent with the anti-
inflammatory properties of EPG demonstrated in this
study. Therefore, the gene expression of NF-κB activating
protein (NKAP) and STAT-3 was investigated in this study
as iNOS is mainly produced via these transcriptional
factors. Based on the data shown, EPG significantly re-
duced the expression of STAT-3 but not NKAP expres-
sion (Fig. 4). The expression of NKAP was unchanged
(Fig. 4, panel a) whereas as indicated earlier, LPS-
dependent induction of STAT-3 was markedly (p < 0.05)
suppressed by EPG (Fig. 4, panel b). EPG also showed
better reduction in the LPS-induced expression of
STAT-3 (Fig. 4, panel b) in RAW 264.7 cells when com-
pared to dexamethasone and aspirin. Therefore, it is per-
tinent to suggest that EPG exerts its anti-inflammatory
activity by suppressing JAK2-STAT pathway. Phan
reported that P.giganteus has high glycine (non-essential
amino acid) content which acts on inflammatory cells to
suppress activation of transcription factors and the forma-
tion of free radicals and inflammatory cytokine [26, 27].
Fig. 4 Effect of ethanol extract of P. giganteus (EPG) on the NF-kB (a) and STAT-3 (b) expression in lipopolysaccharide (LPS)-stimulated RAW 264.7
macrophage cells. Results are expressed as fold of increase compared to LPS treatment as control. Fold increase values are calculated relative to
the ACTB gene. Control = cell treated with LPS only; Dexa = dexamethasone; Asp = Aspirin; EPG = ethanol extract of P. giganteus at 10 μg/mL. Data
expressed as mean ± S.D (n = 3). The different alphabets denote significant difference (p < 0.05) from the corresponding value for control
Fig. 5 Effects of lipopolysaccharide (LPS), hydrogen peroxide (H2O2) and the combination effect of LPS and H2O2 on the production of NO by
the RAW 264.7 macrophage cells. Untreated cells were used as the control. Data expressed as mean ± S.D (n = 3). The different alphabets denote
significant difference (p < 0.05) from the corresponding value for control
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Hence, this could cause the reduction of inflammatory
mediators by EPG as mentioned above.
Inflammation and oxidative stress are closely linked
phenomenon. Oxidative stress occurs when there is
an imbalance of reactive oxygen species (ROS) such
as superoxide radical (O2
- ), hydrogen peroxide (H2O2)
and hydroxyl radical (OH) and the antioxidant de-
fences. This condition can cause damage to cell struc-
ture and function which leads to inflammation. Hseu
reported that Antrodia camphorata, a new basidio-
mycete in the Polyporaceae (Aphyllophorales), attenu-
ated the LPS-induced ROS production [28].
Therefore, in order to assess the protective effect of
EPG against concurrent occurrence of inflammation
and oxidative stress, the following experiments were
carried out. Firstly, NO production was measured
with the stimulation of H2O2 only, LPS only and the
combination of LPS and H2O2 in RAW 264.7 cells.
Figure 5 shows the differences in the production of
NO using different stimulators. The NO production
in RAW 264.7 cells treated with H2O2 only
(0.125 μM) was comparable to the basal level which
was similar to the finding reported by Eguchi using
the BV-2 microglial cells [29]. The plausible explan-
ation for this discrepancy is the absence of phagocytes
which are usually triggered in the presence of patho-
gens or infection (eg. LPS), which in turn lead to the
release of NO. However, LPS (1 μg/ml) induced NO pro-
duction in the presence of H2O2 was significantly (p <
0.05) enhanced (37.6 μM) when compared to cells
treated with only LPS (25.4 μM). This could be due to
the ability of H2O2 to diffuse throughout the mitochon-
dria and across cell membranes and act as a signal initi-
ation molecule in enhancing NO production by LPS via
the expression of IFNβ which inevitably leads to inflam-
mation [30–32]. An overproduction of NO and accu-
mulation of H2O2 will cause cellular damage and
toxicity to the cell. Thus, there will be limited antioxi-
dants to scavenge these oxidants and hence oxidative
stress occurs. This study supports the insights into the
co-relation between ROS-induced oxidative stress and
inflammation.
Fig. 6 Effects of ethanol extracts of P.giganteus (EPG) by LPS (1 μg/ml) / H2O2 (0.125 μM) – induced nitric oxide (NO) production by RAW 264.7
macrophage cells. EPG = ethanol extract of P.giganteus (10 μg/ml); L-NAME = L-NG-Nitro arginine Methyl Ester (100 μM). Data expressed as mean
± S.D (n = 3). The different alphabets denote a significant difference (p < 0.05) from the corresponding value for control
Fig. 7 Effects of ethanol extract of P. giganteus on the iNOS expression in LPS, H2O2 and combination of LPS and H2O2 stimulated RAW 264.7
macrophage cells. Results are expressed as fold of increase compared to LPS treatment as control. Fold increase values are calculated relative to
the ACTB gene. EPG = ethanol extract of P. giganteus. Data expressed as mean ± S.D (n = 3). The different alphabets denote significant difference
(p < 0.05) from the corresponding value for control
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Miligan also reported that LPS-induced iNOS and NO
production were enhanced in the presence of H2O2 and
that H2O2 augmented the steady-state level of iNOS
mRNA [32]. To study the effects of EPG on the combin-
ation effect of LPS and H2O2 on the production of NO by
the RAW 264.7 macrophage cells, cells were primed with
EPG at 10 μg/ml and co-incubated with LPS and H2O2 to
induce the enhanced production of NO by the cells. There
was a significant (p < 0.05) reduction of NO production
(28.69%) by the RAW 264.7 cells when treated with EPG
(Fig. 6) despite having a highly activated NO production.
EPG showed comparable reduction with L-NAME
(33.25%) in NO production.
Similarly the iNOS gene expression was tested to con-
firm the inhibitory effect of EPG on the RAW 264.7
macrophage cells. As shown in Fig. 7, EPG significantly
(p < 0.05) down regulated (8.47 fold) the iNOS gene
expression as compared to the LPS and H2O2-induced
macrophage cells. The inhibition of iNOS expression
was very high but the inhibition of NO production was
not as great. We are unable to give an explanation based
on our present data. Nevertheless, we postulate that the
existing basal level iNOS (prior to the suppression of the
gene) could contribute to the NO production to a cer-
tain extent. Generally, oyster mushrooms are well known
to be potent anti-inflammatory agents [33] and the
present study supports this view.
In order to further understand the mechanism of
action in LPS and H2O2-induced inflammatory re-
sponse, the GPx gene expression, which is the anti-
oxidant enzyme responsible for the reduction of free
H2O2 to water, was examined. The results in Fig. 8
show that the GPx expression level was higher when
stimulated with LPS and H2O2 compared to LPS or
H2O2 only. The presence of LPS could possibly in-
crease the diffusibility of H2O2 across the cell
membrane. This finding supports an earlier report
which showed that the increase in GPx activity was a
response againts increased availability of H2O2 in the
cells [34]. EPG also showed a 2.4 fold reduction in
GPx expression (Fig. 8). According to Phan, P. gigan-
teus is a mushroom that has high phenolic content
which positively correlates with its antioxidant activity
(free radical scavenging and ferric reducing power)
[26]. Lai also reported that the phenolic compounds
from the pigeon pea (Cajanus cajan L.) correlates with
the high antioxidant activity and possess anti-
inflmmatory effect as well [35]. This could possibly ex-
plain the capability of EPG in inactivating H2O2 (a form of
oxidant). These results enhance the understanding of the
correlation between inflammation and oxidative stress.
Conclusion
In summary, to the best of our knowledge, this study
is the first to report on the anti-inflammatory activity
of EPG by down-regulating LPS-induced NO produc-
tion, iNOS, COX-2 and STAT-3 expression in RAW
264.7 cells. The EPG did not show any cytotoxicity
on the RAW 264.7 cells up to a dose of 10 μg/ml.
EPG was also effective in reducing the iNOS expres-
sion in H2O2 enhanced LPS-induced NO production
in RAW 264.7 cells. The ethanol extract of Pleurotus
giganteus has promising anti-inflammatory activity
which acts via the suppression of the STAT 3 and
COX-2 pathway and may be considered as a func-
tional food.
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Fig. 8 Effect of ethanol extract of P. giganteus on the GPx expression in LPS and H2O2-induced RAW 264.7 macrophage cells. Results are expressed as
fold of increase compared to LPS treatment as control. Fold increase values are calculated relative to the ACTB gene. EPG = ethanol extract of
P. giganteus. Data expressed as mean ± S.D (n = 3). The different alphabets denote a significant difference (p < 0.05) from the corresponding
value for control
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STAT: Janus kinase-STAT; L-NAME: Nω-nitro-l-arginine-methyl ester;
LPS: Lipopolysaccahride; MTT: 3[4, 5-dimethylthiazol-2-yl]-2, 5-
diphenyltetrazolium bromide; NF-κβ: Nuclear factor-kappa beta; NGF: Nerve
growth factor; NKAP: NF-κβ activating protein; NO: Nitric oxide;
NSAID’s: Non-steroidal anti-inflammatory drugs; O2
- : Superoxide anion;
OH: Hydroxyl radical; PBS: Phosphate buffer saline; ROS: Reactive oxygen
species; RT-PCR: Real time-polymerase chain reaction; STAT3: Signal
transducer and activation of transcription 3 protein; TLR4: Toll-like receptor 4;
TNF-α: Tumour necrosis factor alpha
Acknowledgements
The authors thank Mushroom Research Centre, Institute of Biological Science,
University of Malaya and Biochemistry Lab, Department of Biomedical
Science, Faculty of Medicine, University of Malaya.
Funding
This research is supported by the University of Malaya Research Grant
RP0058-13AFR, RP005B-13AFR and the Postgraduate Research Grant PV007/
2012A.
Availability of data and materials
The data generated during and/or analysed during the current study are
available from the corresponding author on reasonable request.
Authors’ contributions
AB: carried out the experiments, data interpretation and manuscript
preparation. VS: participated in the acquisition of funding, mushroom
sampling and editing of the manuscript. KHC: engaged in gene expression
studies. RRM: was involved in statistical analysis. URK: was involved in the
design of the study, coordinating and monitoring of research, data
interpretation and manuscript editing. All authors read and approved the
final manuscript.
Competing interest
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Author details
1Institute of Biological Sciences, Faculty of Science, University of Malaya,
50603 Kuala Lumpur, Malaysia. 2Mushroom Research Centre, Faculty of
Science, University of Malaya, 50603 Kuala Lumpur, Malaysia. 3Department of
Biomedical Science, Faculty of Medicine, University of Malaya, 50603 Kuala
Lumpur, Malaysia.
Received: 7 August 2015 Accepted: 20 December 2016
References
1. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7.
2. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate
immune response. Nature. 2000;406:782–7.
3. Kolb H, Mandrup-Poulsen T. The global diabetes epidemic as a
consequence of lifestyle-induced low-grade inflammation. Diabetologia.
2010;53:10–20.
4. Rubio-Perez JM, Morillas-Ruiz JM. A review: inflammatory process in
Alzheimer’s disease, role of cytokines. Sci World J. 2012;2012:756357. doi:10.
1100/2012/756357.
5. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other
markers of inflammation in the prediction of cardiovascular disease in
women. New Engl J Med. 2000;342:836–43.
6. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation.
Nature. 2008;454:436–44.
7. Abramson SB, Weaver AL. Current state of therapy for pain and
inflammation. Arthritis Res Ther. 2005;7:S1.
8. Lacroix I, Lapeyre-Mestre M, Bagheri H, Pathak A, Montastruc JL.
Nonsteroidal anti−inflammatory drug-induced liver injury: a case–control
study in primary care. Fundam Clin Pharm. 2004;18:201–6.
9. Itokawa H, Morris-Natschke SL, Akiyama T, Lee KH. Plant-derived natural
product research aimed at new drug discovery. J Nat Med. 2008;62:263–80.
10. Phan CW, Wong WL, David P, Naidu M, Sabaratnam V. Pleurotus giganteus
(Berk) Karunarathna and KD Hyde: Nutritional value and in vitro neurite
outgrowth activity in rat pheochromocytoma cells. BMC Complem Altern M.
2012;12:10.
11. Wong WL, Abdulla MA, Chua KH, Kuppusamy UR, Tan YS, Sabaratnam V.
Hepatoprotective effects of Panus giganteus (Berk.) corner against
thioacetamide-(TAA-) induced liver injury in rats. Evid Based Complement
Alternat Med. 2012;2012:170303. doi:10.1155/2012/170303.
12. Phan CW, David P, Naidu M, Wong KH, Sabaratnam V. Neurite outgrowth
stimulatory effects of culinary-medicinal mushrooms and their toxicity
assessment using differentiating Neuro-2a and embryonic fibroblast BALB/
3 T3. BMC Complem Altern Med. 2013;13:261.
13. American Type Culture Collection (ATCC). Product Information Sheet for
ATCC®TIB 71TM. 2011.
14. Dudhgaonkar SA, Thyagarajan Sliva D. Suppression of the inflammatory
response by triterpenes isolated from the mushroom Ganoderma lucidum.
Int Immunopharmacol. 2009;9:1272–80.
15. Kanagasabapathy G, Kuppusamy UR, Malek SNA, Abdulla MA, Chua KH,
Sabaratnam V. Glucan-rich polysaccharides from Pleurotus sajor-caju (Fr.)
Singer prevents glucose intolerance, insulin resistance and inflammation in
C57BL/6J mice fed a high-fat diet. BMC Complem Altern Med. 2012;12:261.
16. Patel S, Goyal A. Recent developments in mushrooms as anti-cancer
therapeutics: a review. 3. Biotech. 2012;2:1–15.
17. Boscá L, Zeini M, Través PG, Hortelano S. Nitric oxide and cell viability in
inflammatory cells: a role for NO in macrophage function and fate.
Toxicology. 2005;2005(208):249–58.
18. Shaw CA, Taylor EL, Megson IL, Rossi AG. Nitric oxide and the resolution of
inflammation: implications for atherosclerosis. Mem Inst Oswaldo Cruz. 2005;
100:67–71.
19. Förstermann U. Nitric oxide and oxidative stress in vascular disease. Pflug
Arch Eur J Phy. 2010;459:923–39.
20. Vincent JL, Zhang H, Szabo C, Preiser JC. Effects of nitric oxide in septic
shock. Am J Respir Crit Care Med. 2000;161:1781–5.
21. Moro C, Palacios I, Lozano M, D’Arrigo M, Guillamón E, Villares A, Martinez
JA, García-Lafuente A. Anti-inflammatory activity of methanolic extracts from
edible mushrooms in LPS activated RAW 264.7 macrophages. Food Chem.
2012;130:350–5.
22. Hur SJ, Choi SY, Lim BO. In Vitro Anti-Inflammatory Activity of Russula
virescens in the Macrophage like Cell Line RAW 264.7 Activated by
Lipopolysaccharide. J Nutr Food Sci. 2012;2(4.):1000142.
23. Yoon HM, Jang KJ, Han MS, Jeong JW, Kim GY, Lee JH, Choi YH. Ganoderma
lucidum ethanol extract inhibits the inflammatory response by suppressing
the NF-κB and toll-like receptor pathways in lipopolysaccharide-stimulated
BV2 microglial cells. Exp Ther Med. 2013;5:957–63.
24. Seibert K, Zhang Y, Leahy K, Hauser S, Masferrer J, Perkins W, Isakson P.
Pharmacological and biochemical demonstration of the role of
cyclooxygenase 2 in inflammation and pain. Proc Nat Ac Sci. 1994;91(25):
12013–7.
25. Zhu ZG, Jin H, Yu PJ, Tian YX, Zhang JJ, Wu SG. Mollugin inhibits the
inflammatory response in LPS-stimulated RAW264. 7 macrophages by
blocking the Janus kinase (JAK)-signal transducers and activators of
transcription (STAT) signaling pathway. Biol Pharm Bull. 2013;36:399–406.
26. Phan CW, David P, Tan YS, Naidu M, Wong KH, Kuppusamy UR, Sabaratnam V.
Intrastrain Comparison of the Chemical Composition and Antioxidant Activity
of an Edible Mushroom, Pleurotus giganteus, and Its Potent Neuritogenic
Properties. Sci Wld J. 2014;2014:378651. doi:10.1155/2014/378651.
27. Zhong Z, Wheeler MD, Li X, Froh M, Schemmer P, Yin M, Lemasters JJ. L-
Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective
agent. Curr Opin Clin Nutr Metab Care. 2003;6(2):229–40.
28. Hseu YC, Wu FY, Wu JJ, Chen JY, Chang WH, Lu FJ, Lai YC, Yang HL.
Antiinflammatory potential of Antrodia Camphorata through inhibition of
iNOS, COX-2 and cytokines via the NF-nB pathway. Int Immunopharmacol.
2005;5:1914–25.
29. Eguchi H, Fujiwara N, Sakiyama H, Yoshihara D, Suzuki K. Hydrogen peroxide
enhances LPS-induced nitric oxide production via the expression of
interferon beta in BV-2 microglial cells. Neurosci Lett. 2011;494:29–33.
Baskaran et al. BMC Complementary and Alternative Medicine  (2017) 17:40 Page 9 of 10
30. Matés JM, Sánchez-Jiménez FM. Role of reactive oxygen species in apoptosis:
implications for cancer therapy. Int J Biochem Cell Biol. 2000;32:157–70.
31. Ray G, Husain SA. Oxidants, antioxidants and carcinogenesis. Indian J Exp
Biol. 2002;40:1213–32.
32. Milligan SA, Owens MW, Grisham MB. Augmentation of cytokine-induced nitric
oxide synthesis by hydrogen peroxide. Am J Physiol. 1996;271:L114–20.
33. Gunawardena D, Shanmugam K, Low M, Bennett L, Govindaraghavan S,
Head R, Ooi L, Munch G. Determination of anti-inflammatory activities of
standardised preparations of plant- and mushroom-based foods. Eur J Nutr.
2014;53(1):335–343.
34. Kuppusamy UR, Chong YL, Mahmood AA, Indran M, Abdullah N,
Vikineswary S. Lentinula edodes (Shiitake) mushroom extract protects against
hydrogen peroxide induced cytotoxicty in peripheral blood mononuclear
cells. Indian J Biochem Biophys. 2009;46:161–5.
35. Lai YS, Hsu WH, Huang JJ, Wu SC. Antioxidant and anti-inflammatory effects
of pigeon pea (Cajanus cajan L.) extracts on hydrogen peroxide-and
lipopolysaccharide-treated RAW264. 7 macrophages. Food Funct. 2012;3(12):
1294–301.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Baskaran et al. BMC Complementary and Alternative Medicine  (2017) 17:40 Page 10 of 10
